MariaMRubinsteinMD

PubMed

• A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).
  Melissa Lumish, M Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth Cohen, Claire Friedman, Rachel Grisham, Jason Konner, Chrisann Kyi, Maria Rubinstein, Tif...> ;Gynecologic Oncology. 2024 Mar 1
• Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer.
  William A Zammarrelli 3rd, Weining Ma, Kevin Espino, Sushmita Gordhandas, Effi Yeoshoua, Sarah Ehmann, Qin Zhou, Alexia Iasonos, Nadeem R Abu-Rustum, Carol Aghajanian,...> ;Gynecologic Oncology. 2023 Nov 1
• 3 citations
  Germline drivers of gynecologic carcinosarcomas.
  Tiffany Y Sia, Sushmita B Gordhandas, Ozge Birsoy, Yelena Kemel, Anna Maio, Erin Salo-Mullen, Margaret Sheehan, Martee L Hensley, Maria Rubinstein, Vicky Makker, Rache...> ;Gynecologic Oncology. 2023 Jul 1
• 4 citations
  Comprehensive analysis of germline drivers in endometrial cancer.
  Sushmita Gordhandas, Eric Rios-Doria, Karen A Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel, Margaret Sheehan, Megha Ranganathan, Dina Green, Anjali Aryamvally, Ang...> ;Journal of the National Cancer Institute. 2023 May 8
• 4 citations
  Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study.
  Maria M Rubinstein, Eric Rios Doria, Jason Konner, Stuart Lichtman, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Tiffany Troso-Sandoval, Claire Friedman, Roisin O'Cearbha...> ;Gynecologic Oncology. 2023 Feb 1
• 2 citations
  Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
  Beryl Manning-Geist, Sushmita Gordhandas, Anjelica Hodgson, Qin C Zhou, Alexia Iasonos, Dennis S Chi, Lora Ellenson, Carol A Aghajanian, Nadeem R Abu-Rustum, Mario Lei...> ;International Journal of Gynecological Cancer. 2022 Dec 5
• 4 citations
  Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer.
  Maria Rubinstein, Sherry Shen, Bradley J Monk, David S P Tan, Angélica Nogueira-Rodrigues, Daisuke Aoki, Jalid Sehouli, Vicky Makker> ;Gynecologic Oncology. 2022 Dec 1
• 12 citations
  Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
  Beryl L Manning-Geist, Ying L Liu, Kelly A Devereaux, Arnaud Da Cruz Paula, Qin C Zhou, Weining Ma, Pier Selenica, Ozge Ceyhan-Birsoy, Lea A Moukarzel, Timothy Hoang, ...> ;Clinical Cancer Research. 2022 Oct 3
• 3 citations
  Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer
  Anastasia Navitski, Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal, Diana Mandelker, Karen Cadoo, Roisin E. O'Cearbhaill> ;Gynecologic Oncology Reports. 2021 Nov 1
• 4 citations
  Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
  Sherry Shen, Maria M. Rubinstein, Kay J. Park, Jason A. Konner, Vicky Makker> ;Gynecologic Oncology Reports. 2021 Aug 1
• 10 citations
  Bevacizumab in advanced endometrial cancer.
  Maria M. Rubinstein, Shannan Dickinson, Priyanka Narayan, Qin Zhou, Alexia Iasonos, Weining Ma, Yulia Lakhman, Vicky Makker> ;Gynecologic Oncology. 2021 Jun 1
• 23 citations
  Targeting obesity-related dysfunction in hormonally driven cancers
  Maria M. Rubinstein, Kristy A. Brown, Neil M. Iyengar> ;British Journal of Cancer. 2021 Apr 28
• 6 citations
  A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
  Maria M. Rubinstein, Rachel N. Grisham, Karen Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman, Roisin E. O'Cearbhaill, Dmitriy Zamarin, Qin Zhou, Alexia Iasono...> ;Gynecologic Oncology. 2021 Jan 1
• 34 citations
  Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
  Maria M. Rubinstein, David M. Hyman, Imogen Caird, Helen Won, Krysten Soldan, Kenneth Seier, Alexia Iasonos, William P. Tew, Roisin E. O'Cearbhaill, Rachel N. Grisham,...> ;Cancer. 2020 Mar 15
• 20 citations
  Optimizing immunotherapy for gynecologic cancers.
  Maria M. Rubinstein, Vicky Makker> ;Current Opinion in Obstetrics & Gynecology. 2020 Feb 1
• 4 citations
  Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah's Witness.
  Maria M. Rubinstein, Cheryl Goss, Scott T. Avecilla, Gregory P. Dubé, Gregory J. Riely, Jodi V. Mones> ;Clinical Case Reports. 2019 Dec 26
• 31 citations
  Clinical outcomes of patients with POLE-mutated endometrioid endometrial cancer
  Marina Stasenko, Irina Tunnage, Charles W. Ashley, Maria M. Rubinstein, Alicia Latham, Arnaud Da Cruz Paula, Jennifer J. Mueller, Mario M. Leitao, Claire F. Friedman, ...> ;Gynecologic Oncology. 2019 Nov 19
• 21 citations
  Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience.
  Maria M. Rubinstein, Darragh Halpenny, Vicky Makker, Rachel N. Grisham, Carol Aghajanian, Karen Cadoo> ;Gynecologic Oncology Reports. 2019 Apr 5
• 19 citations
  Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation.
  Maria M Zlobinsky Rubinstein, Andreas Kaubisch, Milan Kinkhabwala, John F. Reinus, Qiang Liu, Jennifer W. Chuy> ;Journal of Gastrointestinal Oncology. 2017 Dec 1
• 11 citations
  Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.
  Maria M Zlobinsky Rubinstein, Amer Assal, Marina Scherba, Jordan Elman, Rob White, Amit Verma, Marianna Strakhan, Farnoush Mohammadi, Murali Janakiram> ;American Journal of Hematology. 2016 Feb 1
• Palliation and Pleurodesis in Malignant Pleural Effusion: The Role for Tunneled Pleural Catheters.
  Suzuki, K., Servais, E. L., Rizk, N. P., Solomon, S. B., Sima, C. S., Park, B. J., Kachala, S. S., Zlobinsky, M., Rusch, V. W., Adusumilli, P. S.> ;J Thorac Oncol. 2011 Apr
• Join now to see all

Lectures

• A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma. 
  2019 ASCO Annual Meeting - 6/1/2019